NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) announced that it will host a virtual investor event on June 23, 2025, at 8:00 am ET. The event will focus on the firmonertinib clinical program for the treatment of EGFR PACC mutant non-small cell lung cancer (NSCLC).
Register for the event now by clicking here and secure your spot today!
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.